GERON CORP's ticker is GERN and the CUSIP is 374163103. A total of 149 filers reported holding GERON CORP in Q4 2021. The put-call ratio across all filers is 0.23 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $276,397 | -33.0% | 130,376 | +1.4% | 0.00% | -33.3% |
| Q2 2023 | $412,816 | +76.7% | 128,603 | +19.5% | 0.00% | +50.0% |
| Q1 2023 | $233,616 | +0.6% | 107,657 | +12.2% | 0.00% | 0.0% |
| Q4 2022 | $232,199 | +7.5% | 95,950 | +3.9% | 0.00% | 0.0% |
| Q3 2022 | $216,000 | +52.1% | 92,314 | +0.9% | 0.00% | +100.0% |
| Q2 2022 | $142,000 | +59.6% | 91,532 | +40.2% | 0.00% | 0.0% |
| Q1 2022 | $89,000 | +12.7% | 65,271 | +0.9% | 0.00% | 0.0% |
| Q4 2021 | $79,000 | -11.2% | 64,716 | -0.6% | 0.00% | 0.0% |
| Q3 2021 | $89,000 | -3.3% | 65,081 | +0.2% | 0.00% | 0.0% |
| Q2 2021 | $92,000 | -35.7% | 64,939 | -28.1% | 0.00% | 0.0% |
| Q1 2021 | $143,000 | 0.0% | 90,379 | +0.3% | 0.00% | 0.0% |
| Q4 2020 | $143,000 | -12.3% | 90,119 | -3.8% | 0.00% | -50.0% |
| Q3 2020 | $163,000 | +7.9% | 93,647 | +35.2% | 0.00% | 0.0% |
| Q2 2020 | $151,000 | +169.6% | 69,253 | +47.7% | 0.00% | +100.0% |
| Q1 2020 | $56,000 | – | 46,901 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 23,375,839 | $49,556,779 | 7.30% |
| MPM BioImpact LLC | 10,712,481 | $22,710,460 | 6.06% |
| Ally Bridge Group (NY) LLC | 2,221,639 | $4,709,875 | 5.53% |
| Vivo Capital, LLC | 16,524,634 | $35,032,224 | 3.84% |
| NEA Management Company, LLC | 22,776,409 | $48,285,987 | 3.73% |
| Deep Track Capital, LP | 25,700,000 | $54,484,000 | 2.10% |
| RA Capital Management | 46,202,425 | $97,949,141 | 1.93% |
| Velan Capital Investment Management LP | 778,500 | $1,650,420 | 1.33% |
| Opaleye Management Inc. | 1,915,000 | $4,059,800 | 1.32% |
| Nan Fung Group Holdings Ltd | 753,550 | $1,597,526 | 1.29% |